The effect of infliximab on skin lesions in a patient with scleroderma (CREST)

Documenti analoghi

• Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment
  di: De Rycke, L, et al.
  Pubblicazione: (2003)
• Differential expression and response to infliximab treatment of specific macrophage subsets in inflammatory synovitis
  di: De Rycke, L, et al.
  Pubblicazione: (2004)
• The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
  di: van Damme, N, et al.
  Pubblicazione: (2002)
• Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor α
  di: Van den Bosch, F, et al.
  Pubblicazione: (2001)
• Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy
  di: Kruithof, E, et al.
  Pubblicazione: (2005)